2项脑机接口医疗器械行业标准立项，医疗器械指数ETF（159898）盘中涨超1%

Group 1 - The medical device sector is experiencing a catalyst with the approval of two major standards in the brain-computer interface (BCI) field, leading to a rise in the medical device index ETF (159898) by approximately 0.88% [1][3] - The National Medical Products Administration has approved the establishment of two industry standards related to BCI technology, which addresses common challenges in the industry and aligns with previous government initiatives to promote innovation in the BCI sector [3] - The fourth largest weight stock in the medical device index ETF, Lepu Medical, announced an expected net profit of 800 million to 1.2 billion yuan for 2025, representing a year-on-year growth of 223.97% to 385.95% due to stable growth in cardiovascular intervention and contributions from new sectors [3] Group 2 - The medical device sector is seen as a strategic focus for the country, with policies aimed at optimizing competition and accelerating innovation in response to technological breakthroughs, including BCI and AI medical technologies [4] - The CSI All Share Medical Device Index includes 103 constituent stocks, focusing on medical equipment, consumables, and in vitro diagnostics, with a significant exposure to the BCI concept at 23.79% [7] - The index has shown impressive performance with a total return of 1015.07% since its inception and an annualized return of 20.86% over the past year, indicating a recovery in the industry's fundamentals [8]